AnGes
4563.TTSE GROWTHPharmaceutical
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Growth Partners Co., Ltd. | 29.74% |
| Noriatsu Furukawa | 15.39% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Athos Capital Limited | 2.93% |
| Merrill Lynch International | 0.03% |
| Cantor Fitzgerald Europe | 0.00% |
| BofA Securities, Inc. | 0.00% |
| BofA Securities Japan Co Ltd | 0.00% |
Ownership history · 45
| Holder | Ratio | Change |
|---|---|---|
| Merrill Lynch International2024-04-12 | 0.03% | -0.24pp |
| Cantor Fitzgerald Europe2024-04-08 | 19.84% | new |
| BofA Securities, Inc.2024-03-05 | 0.00% | new |
| Merrill Lynch International2024-03-05 | 0.27% | new |
| BofA Securities Japan Co Ltd2024-03-05 | 13.70% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.